ELETRIPTAN HYDROBROMIDE
Generic: ELETRIPTAN HYDROBROMIDE
Apnar Pharma LPManufacturer
ORALRoute
ELETRIPTAN HYDROBROMIDEActive Substance
2022-07-13Original Approval
ELETRIPTAN HYDROBROMIDE is FDA application ANDA215467, sponsored by REGCON HOLDINGS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Top Reported Reactions
1
DRUG INEFFECTIVE
103 reports
2
HEADACHE
67 reports
3
NAUSEA
47 reports
4
PAIN
46 reports
5
OFF LABEL USE
43 reports
6
MIGRAINE
41 reports
7
PARAESTHESIA
33 reports
8
VOMITING
33 reports
9
PRODUCT USE IN UNAPPROVED INDICATION
27 reports
10
ANXIETY
26 reports